z-logo
open-access-imgOpen Access
Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases
Author(s) -
Carolina Gubert,
Geraldine Kong,
Thibault Renoir,
Anthony J. Hannan
Publication year - 2019
Publication title -
neurobiology of disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.205
H-Index - 166
eISSN - 1095-953X
pISSN - 0969-9961
DOI - 10.1016/j.nbd.2019.104621
Subject(s) - gut flora , dysbiosis , microbiome , disease , neuroscience , gut–brain axis , amyotrophic lateral sclerosis , multiple sclerosis , biology , medicine , immunology , bioinformatics , pathology
The last decade has witnessed an exponentially growing interest in gut microbiota and the gut-brain axis in health and disease. Accumulating evidence from preclinical and clinical research indicate that gut microbiota, and their associated microbiomes, may influence pathogenic processes and thus the onset and progression of various diseases, including neurological and psychiatric disorders. In fact, gut dysbiosis (microbiota dysregulation) has been associated with a range of neurodegenerative diseases, including Alzheimer's, Parkinson's, Huntington's and motor neuron disease, as well as multiple sclerosis. The gut microbiota constitutes a dynamic microbial system constantly challenged by many biological variables, including environmental factors. Since the gut microbiota constitute a changeable and experience-dependent ecosystem, they provide potential therapeutic targets that can be modulated as new interventions for dysbiosis-related disorders, including neurodegenerative diseases. This article reviews the evidence for environmental modulation of gut microbiota and its relevance to brain disorders, exploring in particular the implications for neurodegenerative diseases. We will focus on three major environmental factors that are known to influence the onset and progression of those diseases, namely exercise, diet and stress. Further exploration of environmental modulation, acting via both peripheral (e.g. gut microbiota and associated metabolic dysfunction or 'metabolopathy') and central (e.g. direct effects on CNS neurons and glia) mechanisms, may lead to the development of novel therapeutic approaches, such as enviromimetics, for a wide range of neurological and psychiatric disorders.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom